AI주식인사이트AI Stock Insight
C

더블유에스아이

299170KOSDAQ생활용품 도매업

41.5 / 100

Reference Date: 2026-04-13

Financial Score10.0 / 40
News Sentiment12.5 / 25
Momentum9.0 / 20
Disclosure10.0 / 15
AI Analysis: the high debt ratio poses financial risk, ROE is below the industry average. Declined 10.6% over the past month, with no recent news.

Company InformationBased on 2025 Annual Report

Business Overview

Double WSI is expanding its business beyond spine and joint medical device distribution by developing surgical assist robots and acquiring pharmaceutical companies. The company is creating vertical and horizontal synergies through a three-pronged business model (distribution-pharmaceuticals-medical robots), having acquired a pharmaceutical firm, Introvapharma, and a clinical trial analysis company, IBP Lab, to grow into a comprehensive healthcare enterprise.

Number of Employees

29people

Average Salary

47.7M KRW

Score Calculation Basis

Detailed Financial Score

PER
—Industry Average 14.254.0Point
PBR
1.62Industry Average 0.750.0Point

2.2x industry avg (risky)

ROE
-6.45Industry Average 0.060.0Point

Well below industry avg

Debt Ratio
25.79Industry Average 11.050.0Point

2.3x industry avg (risky)

Trend 2023~20256.0 / 10 points
Revenue Growth Rate
3.0 / 3

Avg ▲29.4% (2-year basis)

Operating Profit Growth Rate
2.0 / 3

Avg ▲8.4% (2-year basis)

ROE Trend
1.0 / 4

Avg ROE 1.2% (declining, 3yr)

Detailed News Sentiment

0 totalPositive 0Neutral 0Negative 0

Detailed Momentum

52-week position3.0Point

52w lower range (36%)

Current 2,450Won52-week high 4,18052-week low 1,460
1-month return1.0Point

1m -10.58% (falling)

Volume trend5.0Point

Volume flat

Detailed Disclosure

4 totalPositive 0Neutral 4Negative 0
  • Neutral주식등의대량보유상황보고서(약식)2026-04-09
  • Neutral정기주주총회결과2026-03-27
  • Neutral사업보고서 (2025.12)2026-03-19
  • Neutral감사보고서제출2026-03-18